CompoSecure Inc (CMPO)

Curative Biotechnology, Inc. (OTC: CUBT) has structured its recent corporate operations to submit an application to uplist from the base OTC Pink open market to the OTCQB Venture Market.As of June 2026, the specific sequencing, prerequisites, and timeline for Curative's OTCQB application involve the

instability. We believe that our current space efforts will catalyze transformative breakthroughs that could reshape terrestrial industries and lead to the emergence of new trillion-dollar markets on the Moon, Mars, and beyond. In particular, we believe our goal of establishing a lunar presence will

“You’ve been warned.

This approval might become a “sell the news” event. In any case, OLC will fail commercially (i.e. not achieve $1 billion in sales before patent expiration) because Unicycive isn’t operating in a fair marketplace. The marketplace for phosphate binders is basicall

The commercial along with Trump's comments about 1T companies will give renewed attention.
Hopefully the real thing is happening soon.

X, could you DM me your burner email? I have more to share over the weekend and reached the private message limit. TAM SAM SOM lol

of 2026.
prospectussummarya.jpg
1
Table of Contents
PROSPECTUS SUMMARYThis summary highlights information contained elsewhere in this prospectus. This summary is not complete and does not contain all of the information you should consider before investing in our Class A c

Over 225 weeks, and still NO website or brand....

"Feb 10, 2022 - In the coming weeks, the Company expects to be ready to formally launch the Spydasilk website and brand."

https://www.kraiglabs.com/kraig-biocraft-laboratories-delivers-dragon-silk-to-spydasilk-enterprise

I am not going to pigeon hole them to specific timelines or dates. But they should have a strategy to raise awareness, improve presentation and have a professional approach to communication. They never wanted to be a penny stock and are developing an asset to potentially become the gold standard f

Another day….

Another week….

Another word-salad PR….

Another big, fat, juicy, KBLB nothingburger….

with a side order of lies….

https://i.imgflip.com/3bm6mk.jpg

SPX 60 min Chart. 60 min level Current Cycle Between Cycles (CCBC) 0 (Neutral). 60-E-2 (Overdue) confirmed at the close of the 5TH hour. Next possibilities: 60-S-1 (Extreme Overdue) 7399.80, 60-1 (Extreme Overdue) 7360.13, 60-E-1 7249.15 & 6TH UPRO Buy Signal.

https://investorshub.adv

SPX 60 min Chart. 60 min level Current Cycle Between Cycles (CCBC) 0 (Neutral). 60-E-2 (Overdue) confirmed at the close of the 5TH hour. Next possibilities: 60-S-1 (Extreme Overdue) 7399.80, 60-1 (Extreme Overdue) 7360.13, 60-E-1 7249.15 & 6TH UPRO Buy Signal.

https://investorshub.adv

I stick with my charts. HAWK

I follow my charts. When the chart changes I change. You have to be nimble to trade pennies. HAWK

*****BREAKING NEWS*****3RD DAY IN A ROW SHARE PRICE DIPS INTO 10s*****

Nice green close on a Friday. Time to ramp up for SUMMER MANIA soon ;)

brazen22,

Your concerns need to be dealing with how to disavow the check downs on bias done within the study. The regulators accepted or approved the SAP based on this check down on bias and JAMA Oncology published because even though mentioning possible sources of concern the check

Hey Lenny sell the place to a Data Centers they could at least put the water to good use.

Having an internal timeline is great.

Predicting what MHRA will do is clearly a problem.

I know you are not suggesting that NWBO predicted that the application was going to set the record for the longest, or one of the longest, applications in the history of the MHRA.

Or commitments on funding.

Lets goooooo!!!!!

Fair enough....like most OTC "investors" I definitely learned my lessons the hard way. Had a couple of good runners years ago that I held my entire position far too long. That was my mistake.

You are correct that the vast majority of pinks are pure junk and will crash at some point.

"Canary's HBAR ETF files to add staking..."

https://x.com/TokenRelations/status/2065479106527899775

"...What’s happening: On May 21, Canary Capital filed an updated prospectus for its Canary HBAR ETF, which it seeks to list on the Nasdaq. The update would permit the fun

Good use of AI prompts..

Probably 4 months+ after form10 and I think Respire could delay until say closer to IND.

I think folks need to spend some time conversing with AI to understand how valuable KRM-ll-81 can be and why a BP could salivate over such asset even befo

A little more than  3 weeks until the IDE decision. An approval will start human trials at the Mayo Clinic . IsoPet gaining traction . Over 1200% increase year over year . Let’s not forget the DCGI in India and the licensing potential of PrecisionGel .This share price won’t last . Neither will the b